More Cases of Thrombosis After AstraZeneca Vaccine in the UK
In the UK, a total of 168 cases of severe blood clots have been identified in people who received the AstraZeneca vaccine—converted to almost 8 cases per million doses administered.
Last week, the British medicine watchdog counter was still at a hundred, which equated to almost 5 cases per million doses. According to experts, the increase was to be expected. The number of deaths from thrombosis after administering the vaccine increased by 10 to 32, but the death rate decreased relatively slightly.
In the UK, more than 21 million people have had a first AstraZeneca shot. It is advisable to give people under 30 years of age a different vaccine before their second injection. The UK regulator continues to argue that the benefits of the AstraZeneca vaccine outweigh the drawbacks. The European Medicines Agency (EMA) agrees.
There have long been concerns about the infrequent but severe side effects of the British-Swedish pharmaceutical’s vaccine.
In some countries, it is therefore recommended that the drug is only given to the elderly. The EU has now decided not to call on AstraZeneca for additional corona vaccines for the time being. This also has to do with the delayed delivery.